-Lumicell, Inc., a technology leader in the field of image-guided cancer surgery, today announced the company’s progress with its product development of the Lumicell System, as well as the expansion of patent protection for the company’s product and technologies. The foundation of Lumicell’s product development plan is the integration of three proprietary components: the immuno- and cancer-targeted optical contrast agent LUM015, the Lumicell handheld imaging device, and the company’s customized software for real-time display.
http://www.businesswire.com/news/home/20170810005221/en/Lumicell-Announces-Product-Development-Progress-LUM015-Lumicell
Lumicell Announces Product Development Progress with LUM015 in Lumicell System for Image-Guided Cancer Surger